Cardiogenic Shock Working Group Registry
Recruiting
Observational Study
Cardiogenic Shock
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 5,000 (estimated)
- Sponsor
- Tufts Medical Center · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The Cardiogenic Shock Working Group is a multicenter registry where we collect de-identified clinical variables from the medical records and follow-up phone calls of shock patients from multiple institutions and centralize this data to a single registry for analysis of clinical outcomes.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients must have cardiogenic shock.
Cardiogenic shock is defined by at least one of the two categories below:
1. At least 2 of the following concurrently at any point during the index hospitalization:
* Cardiac Index \< 2.2
* PAPI \< 1.0
* Cardiac Power Output ≤ …
Contacts